Efficiency and Safety of Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody on Hypercholesterolemia: A Meta-Analysis of 20 Randomized Controlled Trials

BACKGROUND: Proprotein convertase subtilisin/kexin9 (PCSK9) monoclonal antibody significantly reduces low-density lipoprotein cholesterol level in patients with hypercholesterolemia. The goal of this study was to review recently reported randomized controlled trials to investigate the therapeutic ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chuanwei, Lin, Ling, Zhang, Wen, Zhou, Liang, Wang, Hongyong, Luo, Xiaoli, Luo, Hao, Cai, Yue, Zeng, Chunyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599534/
https://www.ncbi.nlm.nih.gov/pubmed/26077586
http://dx.doi.org/10.1161/JAHA.115.001937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599534/
https://www.ncbi.nlm.nih.gov/pubmed/26077586
http://dx.doi.org/10.1161/JAHA.115.001937

Ejemplares similares